Apex Sci

Garden Grove, United States Founded: 2019 • Age: 7 yrs Acquired By CenExel
Operator of clinical trial sites

About Apex Sci

Apex Sci is a Healthcare company based in Garden Grove (United States) founded in 2019, and was acquired by CenExel in June 2022. Operator of clinical trial sites. Its chief executive, as recorded, is Howard Hassman. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include Javara Research, Vial and Alcanza Clinical Research; 2 of its 3 listed competitors have raised funding.

Company details

Apex was founded in 2019 and is headquartered in Garden Grove, United States. Clinical trial sites are managed by the company within the healthcare sector, focusing on pharmaceutical and biotechnology research. Services encompass patient recruitment, data collection, and regulatory compliance for various therapeutic areas. Operations are conducted to support efficient trial execution across multiple locations. Leadership is provided by CEO Howard Hassman.

  • Headquarters Garden Grove, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website apexsci.com
  • Social LinkedIn
  • Acquired by CenExel (Jun 2022)
Key Metrics

Investors in Apex Sci

Apex Sci has secured backing from 1 investor. Prominent investors backing the company include CenExel.

All
InvestorDescriptionFounded YearDomainLocation
Research site management and patient recruitment services are provided.
2019cenexelresearch.comSalt Lake City, United States
Premium access

Investor details for Apex Sci

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Apex Sci

1 people are tracked at Apex Sci (1 in leadership).

NameRoleGroup
Howard Hassman
CEOLeadership
Premium access

Complete people profiles for Apex Sci

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Apex Sci

2 dated milestones of Apex Sci across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Apex Sci is founded.
  2. Exit Acquired by CenExel.

Competitors of Apex Sci

Apex Sci has 3 listed competitors in our database, 2 of them funded. They include Javara Research, Vial and Alcanza Clinical Research.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
javararesearch.com2018Winston-salem, United States$44.98M
Clinical trials for pharmaceuticals are conducted across therapeutic areas.
vial.com2020San Francisco, United States$67M65
Healthcare data capture, clinical trials, and CRO services are provided.
alcanzaclinical.com2021Methuen, United States
Clinical research site network focused on accelerating the development of new therapies by reducing barriers to participation
Premium access

Detailed competitors of Apex Sci

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Apex Sci (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Apex Sci

CenExel Acquires Apex Innovative Sciences
Globenewswire β€’ 4 years ago
Premium access

Complete news archive for Apex Sci

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Apex Sci

Apex Sci was founded in 2019.

Apex Sci is headquartered in Garden Grove, United States. It is registered at Garden Grove, California, United States.

Howard Hassman is the CEO of Apex Sci, as recorded in our data.

Apex was founded in 2019 and is headquartered in Garden Grove, United States. Clinical trial sites are managed by the company within the healthcare sector, focusing on pharmaceutical and biotechnology research. Services encompass patient recruitment, data collection, and regulatory compliance for various therapeutic areas. Operations are conducted to support efficient trial execution across multiple locations. Leadership is provided by CEO Howard Hassman.

Apex Sci's top competitors include Javara Research, Vial and Alcanza Clinical Research.

Apex Sci has 1 investor. Key investors include CenExel.

Yes. Apex Sci was acquired by CenExel in June 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available